AGM/EGM30 Sept 2026, 04:27 pm
Titan Biotech Increases Authorized Share Capital by ₹40 Lakhs
AI Summary
Titan Biotech Limited announced an increase in its authorized share capital from ₹10 Crore to ₹10.40 Crore. This alteration, approved at the 34th Annual General Meeting held on September 29, 2026, involves the creation of 20,00,000 new equity shares of ₹2 each. The company's Memorandum of Association (MOA) has been amended accordingly. The total authorized capital now stands at ₹10,40,00,000 divided into 5,20,00,000 equity shares of ₹2 each. This move is in compliance with SEBI Listing Regulations.
Key Highlights
- Authorized share capital increased by ₹40 Lakhs.
- AGM approved the alteration of MOA's capital clause.
- New equity shares created to accommodate the increase.
- Company complies with SEBI Listing Obligations.
Price Impact
More from TITANBIO